Fingerprint
Dive into the research topics of 'Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies
Ruben A. Mesa, Stacie Hudgens, Lysbeth Floden, Claire N. Harrison, Jeanne Palmer, Vikas Gupta, Donal P. McLornan, Mary F. McMullin, Jean Jaques Kiladjian, Lynda Foltz, Uwe Platzbecker, M. Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, Andrew Perkins, Michael F. Leahy, Samineh Deheshi, Rafe Donahue, Barbara J. Klencke
Research output: Contribution to journal › Article › peer-review
8
Citations
(Scopus)